The ICN is particularly emphasized the need to see the issue of falsified medicines as ‘a symptom of a larger problem’, namely a lack of access to high-quality, affordable and effective healthcare. The Council is encouraging the Member State Mechanism to engage with our campaign and to foster collaborative action with important stakeholders in the fight against fake medicines.
This report highlights the urgent need for enhanced education, collaboration, and country-based initiatives to curb the growing global crisis. Geneva, Switzerland July 29th, 2024 – Fight the Fakes Alliance (FTFA) has released its white paper Read more…
The introduction and popularity of new, highly-effective weight loss drugs, which has the same active ingredient (semaglutide) as a diabetes medicine, and available by prescription, have created a situation where market demand greatly exceeds product Read more…
We support and amplify the statements delivered by our members World Heart Federation and US Pharmacopeia and other stakeholders such as Médecins Sans Frontières and International Pharmaceutical Federation on agenda item 13.3 Substandard and falsified Read more…